-
AskBio secures $235m investment to accelerate growth
pharmaceutical-technology
April 23, 2019
Gene therapy company Asklepios BioPharmaceutical (AskBio) has received an investment of $225m from TPG Capital and Vida Ventures to accelerate its long-term growth.
-
Catalent to buy gene therapy manufacturer Paragon for $1.2bn
pharmaceutical-technology
April 23, 2019
Catalent to buy gene therapy manufacturer Paragon for $1.2bn...
-
Gene Therapy Might Prove a Cure for 'Bubble Boy' Disease
drugs
April 18, 2019
They were once imprisoned in plastic bubbles that cut them off from the dangerous, infectious world.
-
Catalent to Acquire Paragon for $1.2B
contractpharma
April 16, 2019
To provide new expertise and capabilities in fast-growing gene therapy space.
-
Fujifilm Accelerates Cell Line Devt. Timelines
contractpharma
April 15, 2019
Introduces a 10-week timeline with its Apollo X Advanced Mammalian Expression System.
-
Paragon Opens New Biomanufacturing Facility in MD
contractpharma
April 15, 2019
New facility is equipped with several 500L and 2000L single-use bioreactors for clinical through commercial material production...
-
Precision NanoSystems launches Clinical Solutions service
cphi-online
April 12, 2019
Clinical Solutions offers clients a flexible, customizable suite of products and services designed to accelerate the clinical and commercial development of Gene and Cell Therapies...
-
BPSA releases guide to production of cell and gene therapies
europeanpharmaceuticalreview
April 10, 2019
The Bio-Process Systems Alliance, the primary international industry association for single-use bio-processing, is pleased to announce the release of its latest whitepaper…
-
Six new licensing deals for drug and gene therapy development firm
europeanpharmaceuticalreview
April 10, 2019
Oxford Genetics has won six new licensing deals for its scalable drug and gene therapy manufacturing in the synthetic biology sector…
-
Are Some Birth Control Methods Doomed to Fail?
drugs
March 13, 2019
Women who get pregnant when using certain contraceptives might have their genes to blame, a new study suggests.